Sabra Healthcare REIT (SBRA) Expected to Announce Earnings on Thursday

Sabra Healthcare REIT (NASDAQ:SBRA) is projected to announce its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect the company to announce earnings of $0.39 per share and revenue of $201.9650 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 13, 2026 at 2:00 PM ET.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS. On average, analysts expect Sabra Healthcare REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Healthcare REIT Price Performance

SBRA stock opened at $18.42 on Thursday. The company has a market capitalization of $4.59 billion, a P/E ratio of 25.58, a price-to-earnings-growth ratio of 1.27 and a beta of 0.67. Sabra Healthcare REIT has a 52-week low of $15.60 and a 52-week high of $19.97. The business has a 50-day simple moving average of $19.01 and a two-hundred day simple moving average of $18.71. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. Sabra Healthcare REIT’s payout ratio is presently 166.67%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. UBS Group began coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 target price for the company. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Four analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Sabra Healthcare REIT currently has an average rating of “Hold” and a consensus price target of $21.11.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of SBRA. CIBC Bancorp USA Inc. purchased a new stake in shares of Sabra Healthcare REIT during the third quarter worth $1,647,000. Coldstream Capital Management Inc. bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter valued at $213,000. Danske Bank A S purchased a new stake in Sabra Healthcare REIT during the 3rd quarter worth about $30,000. Hancock Whitney Corp lifted its holdings in Sabra Healthcare REIT by 1.0% during the 3rd quarter. Hancock Whitney Corp now owns 219,530 shares of the real estate investment trust’s stock worth $4,092,000 after purchasing an additional 2,121 shares in the last quarter. Finally, Harvest Investment Services LLC bought a new position in Sabra Healthcare REIT in the 3rd quarter worth about $273,000. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.